A detailed history of Kestra Advisory Services, LLC transactions in Teva Pharmaceutical Industries LTD stock. As of the latest transaction made, Kestra Advisory Services, LLC holds 37,990 shares of TEVA stock, worth $648,869. This represents 0.0% of its overall portfolio holdings.

Number of Shares
37,990
Previous 43,984 13.63%
Holding current value
$648,869
Previous $714,000 4.2%
% of portfolio
0.0%
Previous 0.0%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$15.81 - $18.96 $94,765 - $113,646
-5,994 Reduced 13.63%
37,990 $684,000
Q2 2024

Aug 14, 2024

BUY
$12.78 - $17.4 $55,759 - $75,916
4,363 Added 11.01%
43,984 $714,000
Q1 2024

May 15, 2024

BUY
$10.67 - $14.43 $422,756 - $571,731
39,621 New
39,621 $559,000
Q1 2023

May 12, 2023

SELL
$8.36 - $11.37 $84,561 - $115,007
-10,115 Reduced 49.67%
10,251 $90,000
Q4 2022

Jan 31, 2023

BUY
$7.95 - $9.48 $42,771 - $51,002
5,380 Added 35.9%
20,366 $185,000
Q3 2022

Nov 01, 2022

SELL
$6.86 - $11.95 $170,505 - $297,017
-24,855 Reduced 62.39%
14,986 $121 Million
Q2 2022

Aug 12, 2022

BUY
$7.38 - $10.4 $217,783 - $306,904
29,510 Added 285.65%
39,841 $300,000
Q1 2022

Apr 26, 2022

SELL
$7.33 - $9.39 $18,823 - $24,113
-2,568 Reduced 19.91%
10,331 $97,000
Q4 2021

Jan 20, 2022

BUY
$7.9 - $10.19 $6,264 - $8,080
793 Added 6.55%
12,899 $103,000
Q3 2021

Oct 19, 2021

BUY
$8.38 - $10.18 $12,628 - $15,341
1,507 Added 14.22%
12,106 $117,000
Q2 2021

Jul 28, 2021

SELL
$9.9 - $11.56 $71,656 - $83,671
-7,238 Reduced 40.58%
10,599 $104,000
Q1 2021

May 10, 2021

SELL
$10.34 - $12.81 $371,971 - $460,826
-35,974 Reduced 66.85%
17,837 $205,000
Q4 2020

Jan 20, 2021

BUY
$8.61 - $11.04 $151,544 - $194,315
17,601 Added 48.61%
53,811 $517 Million
Q3 2020

Nov 12, 2020

BUY
$8.57 - $12.69 $310,319 - $459,504
36,210 New
36,210 $327 Million

Others Institutions Holding TEVA

About TEVA PHARMACEUTICAL INDUSTRIES LTD


  • Ticker TEVA
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 1,110,560,000
  • Market Cap $19B
  • Description
  • Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company offers sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage form...
More about TEVA
Track This Portfolio

Track Kestra Advisory Services, LLC Portfolio

Follow Kestra Advisory Services, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Kestra Advisory Services, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Kestra Advisory Services, LLC with notifications on news.